Home Page ::: Current Cancer Drug Targets

ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)


Volume 17, 9 Issues, 2017


Download PDF Flyer

http://www.currentcancerdrugtargets.com/


Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68th of 213 in

    Oncology


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Ruiwen Zhang


Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.707
5 - Year: 3.446
Scopus CiteScore Metrics: 3.32

Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




Endorsement(s)

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets."

Paul Workman
CRC Centre for Cancer Therapeutics, England

Forthcoming Special Issue(s)

CANCER EPIGENETICS


Guest Editor(s): Aamir Ahmad
Tentative Publication Date: November, 2017
Submit Abstract via Email Download Description
Published Special Issue(s)

TARGETED ANTI-CANCER DRUG DELIVERY


Guest Editor(s): Bo Chen, Chao Zhang, Feng Liang
Download Description
Authors' Comments
In terms of “Current Cancer Drug Targets”, the editor-in-chief and the senior manager have done high quality professional job for this journal. I am happy to work with them.
Thank you very much, Best regards.

Dr. Erxi Wu
(Department of Pharmaceutical Sciences, Fargo, USA)

Has contributed: Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer

Current Cancer Drug Targets

,

Volume 17

-

Number 3



Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017Orphan Drugs and Rare Diseases Europe 2017

Related Journals




Related eBooks



Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science